Moneycontrol
    Moneycontrol PRO
    LAMF
    LAMF

    Biocon to raise up to Rs 600 cr by issuance of commercial papers

    The company’s board has approved issuance of commercial papers up to an amount not exceeding Rs 600 crore in one or more tranches on private placement basis, the company said in a regulatory filing.
    PTI
    April 04, 2025 / 22:14 IST
    Biocon

    Biotechnology firm Biocon on Friday said its board has approved to raise up to Rs 600 crore in one or more tranches on a private placement basis.

    The company’s board has approved issuance of commercial papers up to an amount not exceeding Rs 600 crore in one or more tranches on private placement basis, the company said in a regulatory filing. It, however, did not disclose reasons for raising the capital.

    PTI
    first published: Apr 4, 2025 10:14 pm

    Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347